Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIEZO1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | TTBK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | ARNT2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | AEBP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | ICA1L | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | NEUROG3 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | LDLRAD4 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |